$23.23
3.43 (+17.34%)
Pharmacyclics, Inc. (NASDAQ:PCYC)
CAPS Rating:
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.